BIND Therapeutics

BIND Therapeutics is a clinicalstage nanomedicine platform company developing Accurins a class of highly selective targeted therapeutics

Founded:
2006
Founders:
Noubar Afeyan, Robert Langer
Employees:
51 - 100
  • LinkedIn

BIND Therapeutics's Employee Email Address Formats

BIND Therapeutics uses 5 email formats, with first last (ex. johnsmith@bindtherapeutics.com)
being used 96% of the time.
first_initial lastjsmith@bindtherapeutics.com2%
first lastjohnsmith@bindtherapeutics.com96%
first last_initialjohns@bindtherapeutics.com1%
other_templateother_template@bindtherapeutics.com1%
firstjohn@bindtherapeutics.com1%